DK0833649T4 - Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier - Google Patents

Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier

Info

Publication number
DK0833649T4
DK0833649T4 DK96918707T DK96918707T DK0833649T4 DK 0833649 T4 DK0833649 T4 DK 0833649T4 DK 96918707 T DK96918707 T DK 96918707T DK 96918707 T DK96918707 T DK 96918707T DK 0833649 T4 DK0833649 T4 DK 0833649T4
Authority
DK
Denmark
Prior art keywords
allergies
preparations
prevention
treatment
protein hydrolyzate
Prior art date
Application number
DK96918707T
Other languages
English (en)
Other versions
DK0833649T3 (da
Inventor
Erika Isolauri
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaeoja
Leena Metsaeniitty
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0833649(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Publication of DK0833649T3 publication Critical patent/DK0833649T3/da
Application granted granted Critical
Publication of DK0833649T4 publication Critical patent/DK0833649T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96918707T 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier DK0833649T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
PCT/FI1996/000350 WO1997000078A1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies

Publications (2)

Publication Number Publication Date
DK0833649T3 DK0833649T3 (da) 2003-04-07
DK0833649T4 true DK0833649T4 (da) 2009-07-20

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918707T DK0833649T4 (da) 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier

Country Status (27)

Country Link
US (2) US6506380B1 (da)
EP (1) EP0833649B2 (da)
JP (1) JP3983804B2 (da)
KR (1) KR100494741B1 (da)
CN (1) CN1154506C (da)
AR (1) AR003960A1 (da)
AT (1) ATE230606T1 (da)
BG (1) BG63153B1 (da)
BR (1) BR9607827A (da)
CA (1) CA2224320C (da)
CZ (1) CZ291904B6 (da)
DE (1) DE69625690T3 (da)
DK (1) DK0833649T4 (da)
EE (1) EE03424B1 (da)
ES (1) ES2191103T5 (da)
FI (1) FI104465B (da)
HK (1) HK1010081A1 (da)
IL (1) IL122577A0 (da)
MX (1) MX9710109A (da)
MY (1) MY113912A (da)
NO (1) NO321504B1 (da)
NZ (1) NZ310478A (da)
PL (1) PL185123B1 (da)
RO (1) RO120243B1 (da)
SK (1) SK284245B6 (da)
WO (1) WO1997000078A1 (da)
ZA (1) ZA965088B (da)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0986314B1 (en) * 1997-06-03 2008-09-10 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with sids
IL138002A0 (en) 1999-01-19 2001-10-31 Maxygen Inc Methods for making character strings, polynucleotides and polypeptides having desired characteristics
CA2378426C (en) 1999-08-05 2010-03-23 Societe Des Produits Nestle S.A. Bifidobacteria capable of preventing diarrhea
TR200200301T2 (tr) 1999-08-05 2004-12-21 Societe Des Produits Nestle S.A. Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
WO2001057534A2 (en) * 2000-02-04 2001-08-09 Bioseek Compositions and methods for reducing autoimmunity
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
MXPA03001673A (es) * 2000-09-25 2003-06-09 Nestle Sa Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
EP1593382A1 (en) 2000-10-06 2005-11-09 Société des Produits Nestlé S.A. Use of probiotic lactic bacteria for balancing the skin's immune system
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
JP4376180B2 (ja) 2002-06-04 2009-12-02 ディーエスエム アイピー アセッツ ビー．ブイ． トリペプチドに富むタンパク水解物
ATE402993T1 (de) 2002-06-28 2008-08-15 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
CA2556736C (en) 2004-02-25 2013-02-19 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
MX2007012697A (es) 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
BRPI0618569A2 (pt) * 2005-11-14 2011-09-06 Nestec Sa promoção de toleráncia oral com proteìnas glicadas
CN101420965B (zh) 2006-02-15 2013-08-07 雀巢产品技术援助有限公司 长双歧杆菌在制备预防和治疗炎症的药物中的用途
MY149913A (en) 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
BRPI0713596A2 (pt) * 2006-06-15 2012-10-30 Nestec Sa indução de toleráncia às proteìnas do ovo
RU2468808C2 (ru) * 2007-02-28 2012-12-10 Мид Джонсон Нутришен Компани Способ лечения или предотвращения системного воспаления
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974734A1 (en) † 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CA2712207A1 (en) 2008-01-24 2009-07-30 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
DK2244734T3 (da) 2008-02-01 2016-08-15 Murdoch Childrens Res Inst Fremgangsmåde til induktion af tolerance over for et allergen
PT2265135T (pt) 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
ES2575005T3 (es) 2008-06-13 2016-06-23 Codexis, Inc. Método de síntesis de variantes de polinucleótidos
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
MX2010014500A (es) 2008-06-24 2011-05-30 Codexis Inc Procedimientos biocataliticos para la preparacion de compuestos de prolina biciclica fusionada sustancialmente estereomericamente puros.
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8426178B2 (en) 2008-08-27 2013-04-23 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
SG172891A1 (en) 2009-01-08 2011-08-29 Codexis Inc Transaminase polypeptides
WO2010107644A2 (en) 2009-03-17 2010-09-23 Codexis, Inc. Variant endoglucanases and related polynucleotides
BRPI1010239A2 (pt) 2009-03-31 2016-10-11 Codexis Inc endoglucanases aprimoradas, derivados e seus usos
CA2762616C (en) 2009-06-16 2015-08-18 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
CN102482648B (zh) 2009-06-22 2014-12-10 科德克希思公司 酮还原酶介导的产生α氯代醇的立体选择性途径
WO2011011630A2 (en) 2009-07-23 2011-01-27 Codexis, Inc. Nitrilase biocatalysts
IN2012DN00878A (da) * 2009-08-18 2015-05-22 Nestec Sa
MX341971B (es) * 2009-08-18 2016-09-08 Nestec Sa Una composicion nutricional que comprende cepas de bifidobacterium longum y que reduce los sintomas de la alergia a los alimentos, especialmente en lactantes y niños.
WO2011022548A2 (en) 2009-08-19 2011-02-24 Codexis, Inc. Ketoreductase polypeptides for the preparation of phenylephrine
US8785170B2 (en) 2009-09-04 2014-07-22 Codexis, Inc. Variant CBH2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
EP2478137B1 (en) 2009-09-18 2017-09-13 Codexis, Inc. Reduced codon mutagenesis
CA2781399C (en) 2009-11-25 2015-01-20 Codexis, Inc. Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass
WO2011066457A2 (en) 2009-11-25 2011-06-03 Codexis, Inc. Recombinant beta-glucosidase variants for production of soluble sugars from cellulosic biomass
AU2010329990B2 (en) 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
CN102884178B (zh) 2009-12-08 2014-12-03 科德克希思公司 拉唑化合物的合成
MX2012007681A (es) 2009-12-31 2013-01-29 Pioneer Hi Bred Int Ingenieria de resistencia de plantas a enfermedades causadas por patogenos.
EP2566497B1 (en) 2010-05-04 2015-07-29 Codexis, Inc. Biocatalysts for ezetimibe synthesis
JP2013528374A (ja) 2010-05-10 2013-07-11 パーシード セラピューティクス リミテッド ライアビリティ カンパニー Ｖｌａ４のポリペプチド阻害剤
CA2798937A1 (en) 2010-05-28 2011-12-01 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP2582799B1 (en) 2010-06-17 2017-12-20 Codexis, Inc. Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
CA2804019A1 (en) 2010-06-28 2012-01-12 Codexis, Inc. Fatty alcohol forming acyl reductases (fars) and methods of use thereof
WO2012003299A2 (en) 2010-06-30 2012-01-05 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
US9006460B2 (en) 2010-08-16 2015-04-14 Cardiome International Ag Process for preparing aminocyclohexyl ether compounds
EP2606131B1 (en) 2010-08-20 2017-03-08 Codexis, Inc. Use of glycoside hydrolase 61 family proteins in processing of cellulose
HUE037616T2 (hu) 2010-12-08 2018-09-28 Codexis Inc Biokatalizátorok és eljárások armodafinil szintéziséhez
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2691517A4 (en) 2011-03-30 2015-04-22 Codexis Inc FERMENTATION OF PENTOSES BY A RECOMBINANT MICROORGANISM
US9102963B2 (en) 2011-04-13 2015-08-11 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
US8778652B2 (en) 2011-06-30 2014-07-15 Codexis, Inc. Pentose fermentation by a recombinant microorganism
DK2748317T3 (da) 2011-08-22 2017-07-17 Codexis Inc GH61-glycosidhydrolase-proteinvarianter og cofaktorer der forstærker GH61-aktivitet
WO2013036861A1 (en) 2011-09-08 2013-03-14 Codexis, Inc Biocatalysts and methods for the synthesis of substituted lactams
WO2013048661A1 (en) 2011-09-30 2013-04-04 Codexis, Inc. Fungal proteases
WO2013052101A1 (en) * 2011-10-03 2013-04-11 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
WO2013074650A1 (en) 2011-11-18 2013-05-23 Codexis, Inc. Biocatalysts for the preparation of hydroxy substituted carbamates
WO2013096244A1 (en) 2011-12-20 2013-06-27 Codexis, Inc. Endoglucanase 1b (eg1b) variants
SG11201405990PA (en) 2012-03-23 2014-11-27 Codexis Inc Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
HUE042605T2 (hu) 2012-05-08 2019-07-29 Codexis Inc Biokatalizátorok és kémiai vegyületek hidroxilálására szolgáló eljárások
WO2013170050A1 (en) 2012-05-11 2013-11-14 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
WO2013188313A2 (en) 2012-06-11 2013-12-19 Codexis, Inc. Fungal xylanases and xylosidases
AU2013348272A1 (en) 2012-11-20 2015-05-14 Shell Internationale Research Maatschappij B.V. Pentose fermentation by a recombinant microorganism
EP2928865B1 (en) 2012-12-07 2018-04-11 Merck Sharp & Dohme Corp. Biocatalytic transamination process
JP6618180B2 (ja) 2012-12-21 2019-12-11 コデクシス， インコーポレイテッド キラルアミンを合成するための操作された生体触媒および方法
CA2898495C (en) 2013-01-18 2021-06-01 Codexis, Inc. Engineered biocatalysts useful for carbapenem synthesis
SI2961844T1 (sl) 2013-02-28 2018-11-30 Codexis, Inc. Spremenjeni polipeptidi transaminaze za industrijsko biokatalizo
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
HUE055899T2 (hu) 2013-04-18 2022-01-28 Codexis Inc Átszerkesztett fenilalanin-ammónia-liáz polipeptidek
HUE053379T2 (hu) 2013-11-13 2021-06-28 Codexis Inc Génmódosított imin-reduktázok és eljárások keton és amin vegyületek reduktív aminálására
DK3145536T3 (da) 2014-04-16 2022-01-03 Codexis Inc Modificeret tyrosinammoniaklyase
US9708587B2 (en) 2014-07-09 2017-07-18 Codexis, Inc. P450-BM3 variants with improved activity
HUE053363T2 (hu) 2014-11-25 2021-06-28 Codexis Inc Módosított iminreduktázok és eljárások keton- és aminvegyületek reduktív aminálására
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
HUE062016T2 (hu) 2014-12-22 2023-09-28 Codexis Inc Humán alfa-galaktozidáz variánsok
ES2830725T3 (es) 2015-02-10 2021-06-04 Codexis Inc Polipéptidos cetoreductasa para la síntesis de compuestos quirales
DK3292136T3 (da) 2015-05-07 2021-03-22 Codexis Inc Penicillin-g-acylaser
WO2017007547A1 (en) 2015-07-07 2017-01-12 Codexis, Inc. Novel p450-bm3 variants with improved activity
AU2017260355B2 (en) 2016-05-05 2023-03-30 Codexis, Inc. Penicillin-G acylases
EP3469088B1 (en) 2016-06-09 2023-09-06 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
CA3027189A1 (en) 2016-06-15 2017-12-21 Codexis, Inc. Engineered beta-glucosidases and glucosylation methods
IL264686B2 (en) 2016-08-26 2024-07-01 Codexis Inc Engineered imine reductases and methods for reversible amination of ketone and amine compounds
WO2018129130A1 (en) 2017-01-05 2018-07-12 Codexis, Inc. Penicillin-g acylases
US20180223264A1 (en) 2017-02-03 2018-08-09 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
EP3579867A4 (en) 2017-02-13 2021-03-10 Codexis, Inc. MANIPULATED PHENYLALANINE AMMONIA LYASE POLYPEPTIDES
SG11201909807TA (en) 2017-04-24 2019-11-28 Tesaro Inc Methods of manufacturing of niraparib
CN110831618B (zh) 2017-04-27 2023-08-25 科德克希思公司 酮还原酶多肽及多核苷酸
JP7401902B2 (ja) 2017-05-08 2023-12-20 コデクシス， インコーポレイテッド 遺伝子操作されたリガーゼバリアント
WO2018231462A1 (en) 2017-06-14 2018-12-20 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
WO2019005337A1 (en) 2017-06-27 2019-01-03 Codexis, Inc. PENICILLIN G ACYLASES
KR20200023455A (ko) 2017-06-30 2020-03-04 코덱시스, 인코포레이티드 T7 rna 폴리머라제 변이체
US10738286B2 (en) 2017-06-30 2020-08-11 Codexis, Inc. T7 RNA polymerase variants
WO2019094301A1 (en) 2017-11-07 2019-05-16 Codexis, Inc. Transglutaminase variants
US11535833B2 (en) 2017-12-13 2022-12-27 Glaxosmithkline Intellectual Property Development Limited Carboxyesterase biocatalysts
SG11202004185PA (en) 2017-12-13 2020-06-29 Codexis Inc Carboxyesterase polypeptides for amide coupling
CA3102968A1 (en) 2018-06-12 2019-12-19 Codexis, Inc. Engineered tyrosine ammonia lyase
KR20210031933A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 포스포펜토뮤타제 변이체 효소
WO2020014047A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered purine nucleoside phosphorylase variant enzymes
EP3821015A4 (en) 2018-07-09 2022-07-13 Codexis, Inc. DEOXYRIBOSE-PHOSPHATE MODIFIED ALDOLASES
KR20210030379A (ko) 2018-07-09 2021-03-17 코덱시스, 인코포레이티드 조작된 갈락토스 옥시다제 변이 효소
CN112673091A (zh) 2018-07-09 2021-04-16 科德克希思公司 工程化泛酸激酶变体酶
EP3820833A4 (en) 2018-07-12 2022-08-03 Codexis, Inc. MODIFIED AMMONIA-LYASE PHENYLALANINE POLYPEPTIDES
WO2020028039A1 (en) 2018-07-30 2020-02-06 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
EP3874033A4 (en) 2018-10-29 2022-08-03 Codexis, Inc. MANIPULATED VARIANTS OF DNA POLYMERASE
CA3122524A1 (en) 2018-12-14 2020-06-18 Codexis, Inc. Engineered tyrosine ammonia lyase
EA202191735A1 (ru) 2018-12-20 2021-11-24 Кодексис, Инк. Варианты альфа-галактозидазы человека
EP4003061B1 (en) 2019-07-23 2024-04-24 FrieslandCampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
KR20220106738A (ko) 2019-08-30 2022-07-29 코덱시스, 인코포레이티드 조작된 리파제 변이체
JP2022547523A (ja) 2019-09-12 2022-11-14 コデクシス， インコーポレイテッド １０－アセチル－３，７－ジヒドロキシフェノキサジンに対するペルオキシダーゼ活性
US20220372542A1 (en) 2019-10-02 2022-11-24 Abbott Diabetes Care Inc. Detection of analytes by protein switches
AU2020408066A1 (en) 2019-12-20 2022-06-30 Codexis, Inc. Engineered acid alpha-glucosidase variants
IL296841A (en) 2020-04-10 2022-11-01 Codexis Inc Transaminase transaminase polypeptides
BR112023003606A2 (pt) 2020-08-28 2023-03-28 Codexis Inc Protease recombinante, composição, sequência polinucleotídica recombinante, vetor de expressão, célula hospedeira, métodos para produzir uma protease recombinante e para tratar e/ou prevenir os sintomas de insuficiência pancreática, e, uso
JP2023539634A (ja) 2020-08-28 2023-09-15 コデクシス， インコーポレイテッド 操作されたアミラーゼバリアント
US20220186231A1 (en) 2020-12-11 2022-06-16 Willow Biosciences, Inc. Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
US11898174B2 (en) 2020-12-18 2024-02-13 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
CA3214973A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered guanylate kinase variant enzymes
CA3214972A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered adenylate kinase variant enzymes
CA3215105A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered acetate kinase variant enzymes
EP4314264A1 (en) 2021-04-02 2024-02-07 Codexis, Inc. Engineered cyclic gmp-amp synthase (cgas) variant enzymes
CA3227215A1 (en) 2021-07-30 2023-02-02 Trish Choudhary Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023023621A1 (en) 2021-08-19 2023-02-23 Willow Biosciences, Inc. Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
WO2024150146A1 (en) 2023-01-12 2024-07-18 Novartis Ag Engineered ketoreductase polypeptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
ATE84680T1 (de) † 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
DD281540A5 (de) * 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ATE113441T1 (de) † 1989-10-02 1994-11-15 Sandoz Nutrition Ltd Proteinhydrolysaten.
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
ES2111625T3 (es) * 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
WO1995014485A1 (fr) † 1993-11-23 1995-06-01 Kabushiki Kaisha Wado Doctors Group Composition adjuvante de flore intestinale et appareil et systeme de production
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
DK0833649T3 (da) 2003-04-07
PL185123B1 (pl) 2003-02-28
SK171597A3 (en) 1998-11-04
JPH11510791A (ja) 1999-09-21
EE03424B1 (et) 2001-06-15
EP0833649B1 (en) 2003-01-08
FI104465B (fi) 2000-02-15
RO120243B1 (ro) 2005-11-30
AU710126B2 (en) 1999-09-16
EP0833649B2 (en) 2009-06-03
DE69625690T3 (de) 2009-12-24
US7172756B2 (en) 2007-02-06
US20030113340A1 (en) 2003-06-19
CN1154506C (zh) 2004-06-23
KR100494741B1 (ko) 2005-09-30
ATE230606T1 (de) 2003-01-15
AR003960A1 (es) 1998-09-30
MX9710109A (es) 1998-10-31
NO975832D0 (no) 1997-12-11
AU6127896A (en) 1997-01-15
FI952926A0 (fi) 1995-06-14
ES2191103T3 (es) 2003-09-01
BR9607827A (pt) 1999-11-30
NO321504B1 (no) 2006-05-15
JP3983804B2 (ja) 2007-09-26
BG63153B1 (bg) 2001-05-31
KR19990022914A (ko) 1999-03-25
FI952926A (fi) 1996-12-15
CA2224320A1 (en) 1997-01-03
CZ399797A3 (cs) 1998-06-17
CZ291904B6 (cs) 2003-06-18
CA2224320C (en) 2012-03-20
WO1997000078A1 (en) 1997-01-03
NZ310478A (en) 2000-01-28
NO975832L (no) 1997-12-11
MY113912A (en) 2002-06-29
HK1010081A1 (en) 1999-06-11
EE9700339A (et) 1998-06-15
CN1187772A (zh) 1998-07-15
US6506380B1 (en) 2003-01-14
PL324010A1 (en) 1998-04-27
DE69625690T2 (de) 2003-11-06
BG102144A (en) 1998-12-30
DE69625690D1 (de) 2003-02-13
ES2191103T5 (es) 2009-11-03
IL122577A0 (en) 1998-06-15
EP0833649A1 (en) 1998-04-08
ZA965088B (en) 1997-01-22
SK284245B6 (sk) 2004-12-01

Similar Documents

Publication Publication Date Title
DK0833649T4 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier
DK0815130T3 (da) Caseinphosphopeptid, casein indeholdende samme og fremgangsmåde til præparationen deraf
DE69625368D1 (de) Schweisshemmende deodorierende präparaten
DE69422575D1 (de) System zur Erklärung von Austellungsstücken
BR9607669A (pt) Derivado de hormõnio de peptídeo e processo de proporcionar o mesmo
DK1005475T3 (da) Fremgangsmåde til fremstilling af Glufosinat samt mellemprodukter dertil
NO20001240D0 (no) Kay-A immunsystemprotein
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
NO963049L (no) Modulatorer av forankrende proteinfunksjon
DK145393D0 (da) Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
FI963334A0 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
ATE283706T1 (de) ßGEGEN RACEMISIERUNG STABILISIERTE PHARMAZEUTISCHE ZUBEREITUNGEN VON CILANSETRONß
TR199600932T1 (tr) Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
NO980058D0 (no) Opthalmiske preparater
DK0918521T3 (da) Formulering til behandling og/eller forebyggelse af demens
DE69321576D1 (de) Siliconemulsion
DE69420044D1 (de) Blutregulierende peptide
NO963856L (no) Peptider som inhiberer frigjöringen av pepsin
ATA54397A (de) Mittel zur extraktion von metallionen
DE59606703D1 (de) Portionseinheit zur Zubereitung von Getränken
DK0983076T3 (da) Oxalat-nedbrydende mikroorganismer eller oxalat-nedbrydende enzymer til forebyggelse af oxalatrelaterede sygdomme
DK8893A (da) Medikament til behandling eller forebyggelse af sygdom
KR970037567U (ko) 쉬로우드 스톱퍼